Skip to main content
Clinical Trials/NCT05239312
NCT05239312
Unknown
Not Applicable

Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital

Assiut University0 sites90 target enrollmentMarch 2022

Overview

Phase
Not Applicable
Intervention
Antimicrobial
Conditions
Prosthetic Joint Infection
Sponsor
Assiut University
Enrollment
90
Primary Endpoint
Antibiogram for PJI
Last Updated
4 years ago

Overview

Brief Summary

  1. Setting of antibiogram in orthopedic department
  2. Evaluate the production of biofilm in bacteria isolated from specimens phenotypically and genotypically.

Detailed Description

Increased use of total joint arthroplasties will naturally result in a related increase in the number of prosthetic joint infections (PJIs). PJI is a disastrous complication of orthopedic surgery, frequently leading to prolonged morbidity and increased mortality. Moreover, therapy for PJI is associated with enormous costs. PJI results from numerous factors that lead to inability of periprosthetic immune cells to protect implant surfaces and tissues from bacterial colonization. The most destabilizing factor is the ability of bacteria to adhere to and survive on virtually all natural and synthetic surfaces. Once firmly attached to the surface of an implant, the microorganisms initiate "biofilm" formation, which is a complex of microbial cells embedded in an extracellular matrix composed of proteins, extracellular DNA, and exopolysaccharides, providing protection for bacteria and making them extremely resistant to the immune system and antibiotic. An ineffective empiric antibiotic regimen can be harmful to patients while unnecessary broad-spectrum antibiotics lead to increased resistance. However, healthcare providers often select an antibiotic regimen before bacterial antibiotic sensitivities are available. The Clinical and Laboratory of Standards Institute publishes the M39 Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline, which is a referenced guideline on how to create antibiograms. The antibiogram has multiple uses, including providing guidance for empiric antibiotic therapy, monitoring changes in resistance over time, assisting in formulary decisions and supports antimicrobial stewardship programs to reduce multidrug resistant organisms and the risks of adverse drug events.

Registry
clinicaltrials.gov
Start Date
March 2022
End Date
May 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amina Abd El Aal Mohammed Abd El Aal Makhlouf

Assistant lecturer

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Patients with prosthetic joint infection

Intervention: Antimicrobial

Outcomes

Primary Outcomes

Antibiogram for PJI

Time Frame: 18 months

Percentages of different bacterial species causing prosthetic joint infection and their Antimicrobial sensitivity pattern.

Secondary Outcomes

  • Biofilm formation(18 months)

Similar Trials